A benzodiazepine discontinuation programme does not increase the frequency of contacts with the family practice

Scand J Prim Health Care. 2008;26(2):74-9. doi: 10.1080/02813430801999121.

Abstract

Objective: The efficacy of programmes to reduce long-term benzodiazepine use could be compromised by subsequent increases in contacts with the family practice. In this study the hypothesis was tested as to whether participation in a benzodiazepine discontinuation programme affects the frequency of contacts with the family practice.

Design: A controlled stepped-care intervention programme to decrease long-term benzodiazepine use.

Setting: Family practices in the Netherlands. Subjects. The experimental group consisted of 996 long-term benzodiazepine users and a control group of 883 long-term benzodiazepine users.

Main outcome measures: Practice contacts before and up to 12 months after the start of the programme.

Results: There was a general tendency visible for contacts to decrease during the follow-up time. The course of the number of contacts during the follow-up was not different for the experimental and control groups (p=0.45). The level of non-benzodiazepine prescriptions was generally not altered. The number of non-benzodiazepine prescriptions decreased in benzodiazepine quitters during the follow-up of the programme.

Conclusion: No clinically important differences in practice contacts were observed when the course of the number of contacts and non-benzodiazepine prescriptions were compared between the experimental and control groups. Family practitioners do not have to anticipate an increased workload associated with participation in such a benzodiazepine discontinuation programme.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Benzodiazepines / administration & dosage*
  • Benzodiazepines / adverse effects
  • Drug Prescriptions
  • Family Practice / statistics & numerical data*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Niederlande
  • Outcome Assessment, Health Care
  • Substance Withdrawal Syndrome / prevention & control
  • Time Factors
  • Workload

Substances

  • Benzodiazepines